MINNEAPOLIS, June 06, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce that it has joined the Amazon Web Services ("AWS") Partner Network ("APN") and secured a significant new iRWD™ client, an undisclosed computational biotechnology organization, via the AWS Marketplace. About OneMedNet Corporation ...

MINNEAPOLIS, May 29, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce that it has entered into a non-exclusive three (3)-year Master Services Agreement ("MSA") with an undisclosed U.S.-based medical technology company that affects more than 150 million patients worldwide annually. Pursuant to the MS ...

Healthcare data management firm OneMedNet (NASDAQ:ONMD) saw its shares skyrocket on Thursday, gaining over 150%. Management recently announced a greater than five-fold expansion of its proprietary data network. In addition, ONMD stock may be riding the coattails of strong industry projections. According to the company's press release, the business expansion concerns the proprietary iRWD network and platform. Short for Real World Data, iRWD is a system that handles a range of clinical data categories, includ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number) 6385 Old Shady Oak Road, Suite 250 Eden Prairie, MN 55344 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 800-918-7189 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Secur ...

MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce a greater than five (5)-fold expansion of its proprietary iRWD™ network and platform. Through a series of new network partnership agreements, including one recently signed with an undisclosed nation-wide medical records custodian, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File Number: 001-40386 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorpora ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Securities registered pursuant to Sectio ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 Data Knights Acquisition Corp. (Exact name of registrant as specified in its charter) | Delaware | 86-2076743 | | --- ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40386 Data Knights Acquisition Corp. (Exact name of registrant as specified in its charter) | Delaware | 86-2076743 | | --- ...

IPO and Business Combination - Data Knights Acquisition Corp. completed its initial public offering on May 11, 2021, raising gross proceeds of $117.3 million from the sale of 11,500,000 units at $10.00 per unit[20]. - The company has until August 11, 2023, to consummate its initial business combination, having exercised three one-month extensions[22]. - The proposed business combination with OneMedNet Corporation involves an aggregate value of $200 million, subject to adjustments based on net working capital and transaction expenses[23]. - The company aims to target businesses with total enterprise values ranging from $200 million to $1 billion in the tech sector, focusing on revenue and earnings growth potential[28]. - The company has entered into Voting Agreements with stockholders of the target representing approximately 55% of the outstanding voting power to facilitate the business combination[25]. - The company may need additional financing to complete the business combination, which could include issuing additional securities or obtaining debt financing[30]. - Nasdaq rules require that the business combination must have an aggregate fair market value of at least 80% of the assets held in the trust account[31]. - The company intends to complete its initial business combination with a target business that has a fair market value of at least 80% of the assets held in the trust account[60]. - The company may seek additional financing to complete its initial business combination, targeting businesses larger than what can be acquired with the proceeds from its initial public offering[54]. - The Business Combination requires the approval of stockholders under the Merger Agreement and Nasdaq rules, with a majority of outstanding shares needed for approval[81]. - If the Business Combination is not consummated, the company may conduct redemptions without a stockholder vote under SEC tender offer rules[70]. - The company anticipates that its sponsor, officers, and directors may purchase public shares to increase the likelihood of obtaining stockholder approval for the Business Combination[73]. - The company will not complete the initial business combination until the expiration of the tender offer period, which must remain open for at least 20 business days[83]. - The company must ensure that net tangible assets are at least $5,000,001 after any redemptions to avoid being subject to SEC "penny stock" rules[83]. - Stockholder approval is not required for asset purchases or stock purchases not involving a merger, while direct mergers require approval[72]. - If the initial business combination is not completed by August 11, 2023, the company will cease operations and redeem public shares[95]. - The company intends to redeem public shares as soon as reasonably possible following August 11, 2023, if the initial business combination is not completed[107]. - The redemption price for public shares will be equal to the aggregate amount in the trust account, including interest, divided by the number of outstanding public shares, potentially resulting in a per-share price of $10.20[109]. - The company may continue to seek a different target for the initial business combination if the current one is not approved[94]. Financial Position and Performance - The company has $29,029,416 available for an initial business combination as of December 31, 2022, providing options for liquidity events, capital for growth, or debt reduction[50]. - The company reported a net income of $336,658, consisting of realized and unrealized gains and dividends of $1,371,689, offset by operating expenses of $5,103,731[154]. - As of December 31, 2022, the company had cash of $30,870 outside the Trust Account and investments of $29,029,416 held in the Trust Accounts[156][159]. - The company has not generated any operating revenues to date and does not expect to do so until after the completion of its initial business combination[153]. - The company incurred cash used in operating activities of $940,463 for the year ended December 31, 2022[157]. - The company has not paid any cash dividends on its common stock to date and does not intend to do so prior to the completion of its initial business combination[137]. - The company had $207,081 in outstanding Working Capital Loans as of December 31, 2022, which may be convertible into units at $10.00 per unit[165]. - The company had $2,545,838 in outstanding Extension Loans as of December 31, 2022, related to extending the business combination deadline[167]. - The company incurred $120,000 in fees for office space and administrative support for the year ended December 31, 2022, with a total of $200,000 incurred since inception[163]. - The company has no off-balance sheet financing arrangements or long-term debt obligations as of December 31, 2022[162]. Governance and Management - The board of directors consists of four members, with terms divided into three classes, each serving a three-year term[201]. - The audit committee is composed of independent directors, including Dr. Huh, Mr. Ahmed, and Ms. Undikai, with Ms. Undikai serving as chair[205]. - The compensation committee is also made up of independent directors, with Dr. Huh as chair, and is responsible for reviewing compensation arrangements related to initial business combinations[208]. - The company has established an audit committee charter detailing its principal functions, including oversight of the independent registered public accounting firm[207]. - The company has a Chief Financial Officer, Firdauz Edmin Bin Mokhtar, who has extensive experience in financial management and corporate governance[196]. - Barry Anderson serves as the Chief Executive Officer and has been with the company since its inception, focusing on business development strategies[195]. - The company intends to form a corporate governance and nominating committee as required by law or Nasdaq rules[211]. - The audit committee members are financially literate, and Ms. Undikai qualifies as an "audit committee financial expert" under SEC rules[206]. - The company has no standing nominating committee but allows independent directors to recommend nominees for board selection[211]. - No cash compensation has been paid to any officers for services rendered, except for a monthly payment of $10,000 to an affiliate of the sponsor[216]. - The audit committee reviews all payments made to sponsors, officers, or directors on a quarterly basis[216]. - The company has not established specific minimum qualifications for director nominees, focusing instead on educational background and professional experience[214]. - A Code of Ethics has been adopted for directors, officers, and employees, with copies available on the company's website[215]. - The company intends to disclose any amendments to the Code of Ethics in a Current Report on Form 8-K[215]. - The board considers integrity, professional reputation, and the ability to represent stockholders' interests when evaluating director nominees[214]. - No special compensation or benefit arrangements have been approved for officers and employees outside of standard compensation[216]. - The company does not expect additional controls for reimbursement payments to directors and executive officers[216]. - The board will consider stockholder-recommended director candidates for future elections[213]. Risks and Challenges - The company may face intense competition from other blank check companies and private equity groups, which could limit its ability to acquire larger target businesses[112]. - The lack of business diversification may pose risks as the company focuses on a single industry for its initial business combination[65]. - The company has a material weakness in its internal control procedures for the fiscal year ending December 31, 2022, which may impact its operations[117]. - The company may not be able to complete its initial business combination by the deadline, raising doubts about its ability to continue as a going concern[123]. - The company is required to provide audited financial statements of the prospective target business as part of the tender offer materials, which may limit the pool of potential targets[115]. - The company has obligations under Delaware law to provide for claims of creditors before making distributions to stockholders[107]. - If the initial business combination is not consummated, the company may encounter significant challenges in selecting a suitable target business[123]. - A recent ruling by the Delaware Court of Chancery introduces uncertainty regarding the validity of some authorized and issued shares of Class A Common Stock, which could materially affect the company's business and operations[127]. - The company recognized a material weakness in internal control over financial reporting due to errors in accounting for complex financial instruments[185]. - Management has implemented remediation steps to improve internal control over financial reporting, including enhanced review processes for complex securities[188]. - The company does not expect any material exposure to interest rate risk as its investments are in U.S. government treasury bills or money market funds[179]. - There were no changes in internal control over financial reporting that materially affected the company during the most recent fiscal quarter[191].